Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed, Cisplatin, and Radiation Followed by Docetaxel in Squamous Cell Lung Cancer
NCT02787473Phase 2Unknown
- Sponsor
- Hangzhou First People's Hospital
- Start
- Oct 2016
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in squamous cell carcinoma of the lung (LSCC), sponsored by Hangzhou First People's Hospital. Status: unknown.
02
Drugs
pemetrexed
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT02787473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02787473.